A Study to Quantify Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)

NCT03072979 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2017-03-08

No results posted yet for this study

Summary

Pre-clinical evidence suggests that radiotherapy reduces tumour-associated vasculature. The investigators will conduct a single-arm prospective study to quantify the reduction in tumour vasculature post-radiotherapy

Conditions

  • Spine Metastasis

Interventions

RADIATION

Stereotactic body radiotherapy

Stereotactic body radiotherapy

Sponsors & Collaborators

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-21
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03072979 on ClinicalTrials.gov